Booth Andrew bought ABCL

June 3, 2026 · Form 4 insider transaction

Booth Andrew bought 250,000 shares of AbCellera Biologics Inc. at $0.19 per share, a transaction worth $47.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.